非洲镰状细胞病的医疗费用:刚果的经验

IF 2.2 Q3 HEMATOLOGY Anemia Pub Date : 2016-02-02 DOI:10.1155/2016/2046535

L. Ngolet, M. Moyen Engoba, I. Kocko, A. Elira Dokékias, J. Mombouli, G. Moyen

{"title":"非洲镰状细胞病的医疗费用:刚果的经验","authors":"L. Ngolet, M. Moyen Engoba, I. Kocko, A. Elira Dokékias, J. Mombouli, G. Moyen","doi":"10.1155/2016/2046535","DOIUrl":null,"url":null,"abstract":"Background. Lack of medical coverage in Africa leads to inappropriate care that has an impact on the mortality rate. In this study, we aimed to evaluate the cost of severe acute sickle-cell related complications in Brazzaville. Methods. A retrospective study was conducted in 2014 in the Paediatric Intensive Care Unit. It concerned 94 homozygote sickle-cell children that developed severe acute sickle-cell disease related complications (average age 69 months). For each patient, we calculated the cost of care complication. Results. The household income was estimated as low (<XAF 90,000/<USD 158.40) in 27.7%. The overall median cost for hospitalization for sickle-cell related acute complications was XAF 65,460/USD 115.21. Costs were fluctuating depending on the generating factors of the severe acute complications (p = 0.041). They were higher in case of complications generated by bacterial infections (ranging from XAF 66,765/USD 117.50 to XAF 135,271.50/USD 238.07) and lower in case of complications associated with malaria (ranging from XAF 28,305/49.82 to XAF 64,891.63/USD 114.21). The mortality rate was 17% and was associated with the cost of the case management (p = 0.006). Conclusion. The case management cost of severe acute complications of sickle-cell disease in children is high in Congo.","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2016-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/2046535","citationCount":"14","resultStr":"{\"title\":\"Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo\",\"authors\":\"L. Ngolet, M. Moyen Engoba, I. Kocko, A. Elira Dokékias, J. Mombouli, G. Moyen\",\"doi\":\"10.1155/2016/2046535\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background. Lack of medical coverage in Africa leads to inappropriate care that has an impact on the mortality rate. In this study, we aimed to evaluate the cost of severe acute sickle-cell related complications in Brazzaville. Methods. A retrospective study was conducted in 2014 in the Paediatric Intensive Care Unit. It concerned 94 homozygote sickle-cell children that developed severe acute sickle-cell disease related complications (average age 69 months). For each patient, we calculated the cost of care complication. Results. The household income was estimated as low (<XAF 90,000/<USD 158.40) in 27.7%. The overall median cost for hospitalization for sickle-cell related acute complications was XAF 65,460/USD 115.21. Costs were fluctuating depending on the generating factors of the severe acute complications (p = 0.041). They were higher in case of complications generated by bacterial infections (ranging from XAF 66,765/USD 117.50 to XAF 135,271.50/USD 238.07) and lower in case of complications associated with malaria (ranging from XAF 28,305/49.82 to XAF 64,891.63/USD 114.21). The mortality rate was 17% and was associated with the cost of the case management (p = 0.006). Conclusion. The case management cost of severe acute complications of sickle-cell disease in children is high in Congo.\",\"PeriodicalId\":46055,\"journal\":{\"name\":\"Anemia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2016-02-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2016/2046535\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2016/2046535\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2016/2046535","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 14

摘要

背景。非洲缺乏医疗覆盖，导致护理不当，对死亡率产生影响。在这项研究中，我们旨在评估布拉柴维尔严重急性镰状细胞相关并发症的成本。方法。2014年在儿科重症监护室进行了一项回顾性研究。它涉及94名发生严重急性镰状细胞病相关并发症的纯合子镰状细胞儿童(平均年龄69个月)。对于每位患者，我们计算了护理并发症的成本。结果。27.7%的家庭收入估计较低(< 9万里亚尔/< 158.40美元)。镰状细胞相关急性并发症的住院总中位费用为65,460澳币/ 115.21美元。费用随严重急性并发症的发生因素而波动(p = 0.041)。细菌感染引起的并发症较高(从66,765 XAF / 117.50美元到135,271.50 XAF / 238.07美元)，与疟疾相关的并发症较低(从28,305/49.82 XAF到64,891.63 XAF / 114.21美元)。死亡率为17%，与病例管理费用相关(p = 0.006)。结论。在刚果，儿童镰状细胞病严重急性并发症的病例管理费用很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo

Background. Lack of medical coverage in Africa leads to inappropriate care that has an impact on the mortality rate. In this study, we aimed to evaluate the cost of severe acute sickle-cell related complications in Brazzaville. Methods. A retrospective study was conducted in 2014 in the Paediatric Intensive Care Unit. It concerned 94 homozygote sickle-cell children that developed severe acute sickle-cell disease related complications (average age 69 months). For each patient, we calculated the cost of care complication. Results. The household income was estimated as low (

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Anemia HEMATOLOGY-

CiteScore

4.80

自引率

3.40%

发文量

审稿时长

18 weeks

期刊介绍： Anemia is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies on all types of anemia. Articles focusing on patient care, health systems, epidemiology, and animal models will be considered, among other relevant topics. Affecting roughly one third of the world’s population, anemia is a major public health concern. The journal aims to facilitate the exchange of research addressing global health and mortality relating to anemia and associated diseases.